Jump to content

Big Pharma Strikes Again, Secured Patent On Thc & Cbd


Recommended Posts

Drug Maker Secures Patent on THC and CBD as Cancer Treatment

 

A pharmaceutical company in the United Kingdom, specializing in the research and development of pot-based drugs, recently obtained early approval on a patent covering two specific cannabinoids found in marijuana to be used as treatment for brain cancer.

 

According to a press release, GW Pharmaceuticals will hold the patent rights to the two primary compounds found in marijuana, THC and CBD, for use as medicine for patients suffering from gliomas -- the most common form of malignant brain tumor.

 

The United States Patent Office informed the drug company earlier last week, by way of Notice of Allowance, that a patent application filed several years ago was officially deemed a genuine invention and is now in its final stages of approval.

 

GW Pharmaceuticals must now submit the appropriate fees before final approval for their cancer combatant patent is granted. Try saying that five time fast.

 

“The subject patent specifically covers a method for treating glioma in a human using a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD) with the intent to reduce cell viability, inhibit cell growth or reduce tumor volume,” according to a statement issued by the company.

 

GW’s patent application was originally filed in 2009, which detailed the company’s invention of the “use of a combination of cannabinoids in the manufacture of a medicament for use in the treatment of cancer.” Yet, it is believed the verbiage was revised at some point, noting more specific information, including THC and CBD ratios and the fact that the treatment is used against brain cancer.

 

Justin Gover, GW’s Executive Chief Officer, says that the company recently initiated its first wave of clinical trails to study glioma, a disease that accounts for nearly 50% of new brain cancer diagnoses in the United States each year. “The treatment of glioma is part of our exciting new orphan drug program which includes a number of therapeutic targets and demonstrates the flexibility of GW’s proprietary cannabinoid platform in treating a broad range of disease types.”

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
  • Similar Content

    • By keith mclaughlin
      On this episode of Let’s be Blunt, Montel talks with Mark and Christy Zartler. They are parents to twin daughters, one of which, Kara, suffers from Autism and Cerebral Palsy and struggles with severe self-injurious behavior related to her condition. Whole plant cannabis has helped to relieve some of her symptoms when traditional medications didn’t. That wouldn’t be a problem if they lived in a legal medical cannabis state, but they live in Texas. The Zartler’s risk the wrath of law enforcement and Child Protective Services (when Kara was younger) in order to bring their daughter the only medication that brings her relief from her self injurious behavior. They are sharing their story in hopes of helping other families who are coping with similar situations.
       
       
       
    • By keith mclaughlin
      Montel talks with Kentiuky native Jim Higdon on this episode of Let’s Be Blunt. Jim wrote the first non-fiction account of the Cornbread Mafia which tells the story of the biggest domestic marijuana syndicate in American history, which took place in his hometown of Marion County, Kentucky. With the books success, he became a nationally recognized cannabis journalist, covering Kentucky for the Washington Post and cannabis policy for POLITICO. In 2018, he left journalism to co-found Cornbread Hemp.
       
       
    • By keith mclaughlin
      On this episode of Let’s be Blunt, Montel talks with Lisa Quarrell, a mother who lives in East Kilbride, Scotland, who has been tirelessly campaigning for a National Health Service-funded prescription that her son desperately needs. Her 8-year-old son, Cole, was diagnosed with a rare form of severe epilepsy as a baby and suffered up to 20 seizures a day. He had undergone brain surgery and tried 20 different anti-epileptic drugs before before he was prescribed a life-saving cannabis oil which has helped him tremendously. The coronavirus pandemic has made it difficult for her to afford the medication since the fundraising nights she was having were put on hold. She has since been campaigning to have cannabis oil and medications provided and paid for by the NHS but she continues to struggle with the bureaucracy of the Scottish government and NHS Scotland.
       
       
       
    • By keith mclaughlin
      Imagine your child is sick…and then you discover that there is something that can bring them relief…BUT you must break the law in order to access that it, and risk the wrath of law enforcement, and worse yet, the threat of Child Protective Services knocking on your door one day and taking your child from you. Would you take the risk to help your child? The new documentary “Weediatrics”, explores stories of families at the heart of this issue. These brave parents went on camera to tell their stories, in hope of creating a greater understanding and empathy for desperate families across the country in similar situations. On this episode of Let’s Be Blunt, Montel explores this topic with the films producer, Erin O’Hearn.
       
       
    • By keith mclaughlin
      On this episode of Let’s be Blunt, Montel talks with Gina Vensel and Elizabeth Sheldon, the Co-Founders of the Plant Media Project, a boutique marketing company specializing in services for plant medicine and wellness businesses and co-hosts of the Vine podcast, aimed at providing an insightful look into the world of plant medicine. They discuss everything from their personal experiences with cannabis as patients to regulatory advocacy to business practices.
      https://youtube.com/watch?v=Reg5Jgj0SKw 


×
×
  • Create New...